Phase II study of N‐methylformamide, spirogermanium, and 4‐demethoxydaunorubicin in the treatment of non‐small cell lung cancer (EST 3583): An Eastern cooperative oncology group study

David S. Ettinger, Dianne M. Finkelstein, Ross C. Donehower, Alex Y.C. Chang, Michael Green, Ronald Blum, Richard G. Hahn, John C. Ruckdeschel

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of N‐methylformamide, spirogermanium, and 4‐demethoxydaunorubicin in the treatment of non‐small cell lung cancer (EST 3583): An Eastern cooperative oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences